High‐throughput lipidomic profiles sampled with electroporation‐based biopsy differentiate healthy skin, cutaneous squamous cell carcinoma, and basal cell carcinoma
Skin Research and Technology · 2024
DOI: 10.1111/srt.13706 ↗Kurz gefasst
Fachartikel in der Zeitschrift Skin Research and Technology, 2024. Verfasst von Leetal Louie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Porter School of Environment and Earth Sciences, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Skin Neoplasms, Carcinoma, Squamous Cell, Lipidomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Innovation Authority Kamin project, TAU SPARK fund, TAU Zimin Center for technologies for better life,.
Abstract (Originalsprache)
Background
The incidence rates of cutaneous squamous cell carcinoma (cSCC) and basal cell carcinoma (BCC) skin cancers are rising, while the current diagnostic process is time‐consuming. We describe the development of a novel approach to high‐throughput sampling of tissue lipids using electroporation‐based biopsy, termed e‐biopsy. We report on the ability of the e‐biopsy technique to harvest large amounts of lipids from human skin samples. Materials and Methods Here, 168 lipids were reliably identified from 12 patients providing a total of 13 samples. The extracted lipids were profiled with ultra‐performance liquid chromatography and tandem mass spectrometry (UPLC‐MS‐MS) providing cSCC, BCC, and healthy skin lipidomic profiles.
Results
Comparative analysis identified 27 differentially expressed lipids ( p < 0.05). The general profile trend is low diglycerides in both cSCC and BCC, high phospholipids in BCC, and high lyso‐phospholipids in cSCC compared to healthy skin tissue samples.
Conclusion
The results contribute to the growing body of knowledge that can potentially lead to novel insights into these skin cancers and demonstrate the potential of the e‐biopsy technique for the analysis of lipidomic profiles of human skin tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Porter School of Environment and Earth Sciences, Tel Aviv University, Tel Aviv, Israel.
- Department of Plastic Surgery, Meir Medical Center, Kfar Sava, Israel.
- Department of Pathology, Meir Medical Center, Kfar Sava, Israel.
- Arazi School of Computer Science, Reichman University, Herzliya, Israel.
- Department of Computer Science, Technion - Israel Institute of Technology, Haifa, Israel.
ORCID-Profile: Ariel Berl, Alexander Golberg
Förderung
- Israel Innovation Authority Kamin project
- TAU SPARK fund
- TAU Zimin Center for technologies for better life,
- EuroNanoMed MATISSE
Zitieren
APA
Louie, L., Wise, J., Berl, A., Shir-Az, O., Kravtsov, V., Yakhini, Z., Shalom, A., Golberg, A., & Vitkin, E. (2024). High‐throughput lipidomic profiles sampled with electroporation‐based biopsy differentiate healthy skin, cutaneous squamous cell carcinoma, and basal cell carcinoma. Skin Research and Technology. https://doi.org/10.1111/srt.13706
Vancouver
Louie L, Wise J, Berl A, Shir-Az O, Kravtsov V, Yakhini Z, et al. High‐throughput lipidomic profiles sampled with electroporation‐based biopsy differentiate healthy skin, cutaneous squamous cell carcinoma, and basal cell carcinoma. Skin Research and Technology. 2024. doi:10.1111/srt.13706
BibTeX
@article{Louie2024,
author = {Louie, Leetal and Wise, Julia and Berl, Ariel and Shir-Az, Ofir and Kravtsov, Vladimir and Yakhini, Zohar and Shalom, Avshalom and Golberg, Alexander and Vitkin, Edward},
title = {High‐throughput lipidomic profiles sampled with electroporation‐based biopsy differentiate healthy skin, cutaneous squamous cell carcinoma, and basal cell carcinoma},
journal = {Skin Research and Technology},
year = {2024},
doi = {10.1111/srt.13706}
}
EUVIMED